Advertisement

Topics

Debiopharm continues fight against antibiotic resistance

09:34 EST 15 Feb 2018 | Manufacturing Chemist

Debiopharm Group invests in antibiotic development with the acquisition of a minority stake in ABAC Therapeutics

Original Article: Debiopharm continues fight against antibiotic resistance

NEXT ARTICLE

More From BioPortfolio on "Debiopharm continues fight against antibiotic resistance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...